Plant synthetic biology is a budding field that have pre-historic roots in agriculture. The excitement and possibilities of the future of SynBio is shared by global citizen scientists as well as synthetic biology experts and shaking up industries. There is a massive global appetite for synthetic biology knowledge especially amongst young academics. Synthetic Biology (SynBio) is the space between engineering and biology. It brings together many disciplines in a symbiotic relationship working on the diversity of ideas to understand and work with the design of biology for the future benefit of everything. Synthetization of products has been around since the 1800’s. This process has helped reduce cost and allow for massive scale of medicines and products. Some of the more famous widely used medicines and consumed synthesized products are; Morphine, Aspirin, Vanilla Extract, Vitamin C, Penicillin, Taxol™, Insulin and Wine. Consumers are also getting use to products like synthetic eyelashes. The growing popularity can be seen in many areas such as the synthetic biology project, conferences and summits such as SB7.0 the Global Community Bio summit 3.0 and the annual International Genetically Engineered Machine (IGEM) competition bringing together experts and more than 3,500 young people to better understand synthetic biology and thus normalizing it. The Synthetic Yeast Project 2.0 (SC2.0) brings together 15 labs across 4 continents to look for better ways to genetically engineer yeast to yield more efficient medicines, compounds and products. We can also see the popularity surge in the 1,600 fab labs established worldwide and the dedication to this field by the investment of prestigious institutions such as M.I.T and Princeton. AXIM Biotechnologies is planning on starting their first clinical trials in 2020 using a newly synthesized drug (MedChew), a chewing gum infused with dronabinol, for cancer patient nausea.